Perrigo | PRGO - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AbbVie USD 10.27B 1000K 2026-06
Abbott USD 10.46B 1.15B 2026-06
Bayer EUR 10.04B 168M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Coherus Biosciences USD 51.83M 2.48M 2025-12
Corcept Therapeutics USD 214.85M 343K 2026-06
Dr.Reddys Laboratories INR 77.75B 3.17B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
J&J USD 17.83B 388M 2026-06
Merck USD 15.77B 2.4B 2026-06
Nestle CHF 36.13B 2.29B 2026-06
Pacira USD 180.54M 7.79M 2026-06
Perrigo USD 290.5M 645.1M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Reckitt Benckiser GBP 6.26B 3.51B 2024-12
Sanofi EUR 9.92B 607M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03
Zoetis USD 3.15B 85M 2026-06